This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Albemarle (ALB) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 48.92% and 5.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $185.46, moving -0.29% from the previous trading session.
Analysts Estimate Huntsman (HUN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium prices and volumes and its cost-reduction actions in the first quarter amid headwinds from higher input costs.
Chemours (CC) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 58.06% and 0.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
DuPont (DD) Gears Up for Q1 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is expected to have gained from the strength in water and general industrial and its pricing and productivity actions in the first quarter.
Livent (LTHM) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Livent's (LTHM) Q1 results are expected to reflect the benefits of higher realized pricing and strong lithium demand.
4 Chemical Stocks Poised to Outshine Q1 Earnings Estimates
by Anindya Barman
While softer demand in certain end markets is likely to be a drag, Albemarle (ALB), DuPont (DD), Axalta (AXTA) and LyondellBasell (LYB) are likely to have benefited from cost and pricing actions in Q1.
Albemarle (ALB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CF Industries (CF) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CF Industries' (CF) first-quarter performance will likely reflect the impacts of softer nitrogen prices and high natural gas costs.
Company News for Apr 25, 2023
by Zacks Equity Research
Companies in The News Are: FOXA, ALB, TSLA, AAPL.
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Newmont (NEM) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Newmont's (NEM) first-quarter results are expected to reflect improved grades across a number of mines, improved gold prices and lower unit costs.
Albemarle (ALB) Surges 5.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Albemarle (ALB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Will Albemarle (ALB) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Company News for Apr 24, 2023
by Zacks Equity Research
Companies in The News Are: PG, HCA, RF, ALB.
FMC Corp (FMC) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
FMC Corp.'s (FMC) first-quarter performance is likely to have gained from healthy demand, pricing actions and new products.
Is a Beat in the Offing for Linde (LIN) in Q1 Earnings?
by Zacks Equity Research
Higher industrial production in the March quarter is likely to have aided Linde's (LIN) Q1 earnings.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $205.27, moving -0.31% from the previous trading session.
EPA's New Proposal to Fast Track US EV Sales: 5 Stocks in Focus
by Rimmi Singhi
As EPA's stringent auto emissions standards are set to spur EV sales in the United States, investors should add stocks like GM, TSLA, BWA, ALB and ENS to gain exposure to the thriving industry.
Seeking Lithium Exposure? 3 Stocks Worth Considering
by Derek Lewis
With the EV landscape expected to grow significantly, investors can tap into the market by targeting companies providing the necessary materials needed for production.
EV Infrastructure Investment Opportunities: What Investors Need to Know
by Rimmi Singhi
As demand for EVs grows, stocks like BLNK, CHPT, TSLA, ALB and FSLR warrant a look if you wish to tap the booming EV infrastructure market.
Albemarle (ALB) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $201.70, making no change from the previous trading session.
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Albemarle (ALB) Gains on Strong Demand, Capacity Expansion
by Zacks Equity Research
While Albemarle (ALB) faces headwinds from high input costs, it benefits from higher volumes and prices in its lithium business and actions to boost its global lithium capacity.